High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: Comparison with standard intramuscular vaccination

European Journal of Epidemiology

Volumn 19, Issue 9, 2004, Pages 871-875

  Ghabouli, Mohammad J ^a   Sabouri, Amir Hossein ^a,b   Shoeibi, Naser ^a   Naghibzadeh Bajestan, Sepideh ^b   Baradaran, H ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatitis B vaccination; Intradermal; Intramuscular

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; EVALUATION; FEMALE; GEOMETRY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; IRAN; MAJOR CLINICAL STUDY; MALE; NURSING; POPULATION RESEARCH; SEX RATIO; SIDE EFFECT; SKIN DISCOLORATION; STANDARDIZATION; VACCINATION; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICAL STUDENT; NURSING STUDENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; IRAN; MALE; QUESTIONNAIRES; SMOKING; STUDENTS, MEDICAL; STUDENTS, NURSING;

EID: 16644389994     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000040532.99890.9f     Document Type: Article

References (22)

1. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population - a viral marker study. Ann Acad Med Singapore 1980; 9: 144-148.
2. Farhat A, Khademi G, Mazouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J 2003; 24: 549-551.
3. Deinhardt F, Zuckerman AJ. Immunization against hepatitis B: Report on a WHO meeting on viral hepatitis in Europe. J Med Virol 1985; 17: 209-217.
4. Kane MA. Status of hepatitis B immunization programmes in 1998. Vaccine 1998; 16(Suppl): S104-S108.
5. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000; 31: 521-527.
6. Nothdurft HD, Dietrich M, Zuckerman JN, Knobloch J, Kern P, Vollmar J, Sanger R. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002; 15; 20: 1157-1162.
7. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine 2001; 14; 19: 4544-4548.
8. McLean AA, Hilleman MR, McAleer WJ, Buynak EB. Summary of worldwide clinical experience with H-B-Vax (B, MSD). J Infect 1983; 7(Suppl)1: 95-104.
9. Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992; 14: 697-707.
10. Hadler SC. Are booster doses of hepatitis B vaccine necessary? Ann Intern Med 1988; 108: 457-458.
11. Wainwright RB, McMahon BJ, Bulkow LR, Hall DB, Fitzgerald MA, Harpster AP, Hadler SC, Lanier AP, Heyward WL. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 1989; 28; 261: 2362-2366.
12. Poux JM, Ranger-Rogez S, Lagarde C, Benevent D, Denis F, Leroux-Robert C. Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach. Presse Med 1995; 6-13; 24(17): 803-806.
13. Prasetya E, Linggadjaja W, Syambali R, Kusumo S, Dharmesetyawan DF, Rahardja U. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel - a preliminary report. Ann Acad Med Singapore 1986; 15: 153-157.
14. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/L) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Infection 1995; 23: 42-45.
15. Mok Q, Underhill G, Wonke B, Aldouri M, Kelsey M, Jefferies D. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease. Arch Dis Child 1989; 64: 535-540.
16. Yao FB, Li XX, Du YX, Ye SL. Combined intramuscular-intradermal protocol of universal neonate HB vaccination irrespective of mother's status of HBsAg. Vaccine 1998; 16: 586-589.
17. Coleman PJ, Shaw FE Jr, Serovich J, Hadler SC, Margolis HS. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 1991; 9: 723-727.
18. Brink NS, Murray AB. Intradermal vaccination against hepatitis B in a group of medical students. S Afr Med J 1991; 1; 79: 653-654.
19. Herbert M, Butler AV, Roome AP, Caul EO. Comparison of intradermal and intramuscular hepatitis B vaccination in university students. Vaccine 1989; 7: 395-396.
20. Clarke JA, Hollinger FB, Lewis E, Russell LA, Miller CH, Huntley A, Flynn NM. Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites. JAMA 1989; 10; 262: 2567-2571.
21. Senden TF. Response to intradermal hepatitis B vaccination: Differences between males and females? Vaccine 1990; 8: 612-613.
22. Lankarani KB, Taghavi AR, Agah S, Karimi A. Comparison of intradermal and intramuscular administration of hepatitis B vaccine in neonates. Indian J Gastroenterol 2001; 20: 94-96.